ReModeling in ST-elevation myocARrdial Infarction: a Comparison of Left VEntricuLar Functions in Long-term Follow-up Among STEMI Patients
Launched by UNIVERSITY OF PISA · Jun 19, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the heart’s left side (the left ventricle) changes over time in patients who have had a specific type of heart attack called STEMI and were treated with a procedure to quickly open blocked arteries. The researchers want to understand how the heart heals or remodels after this event by using various tests, including heart ultrasounds and MRI scans, both during the hospital stay and six months later. They will look at things like heart function, heart muscle damage, and signs of inflammation to see how these factors relate to changes in the heart’s size and strength over time.
Anyone who has had a STEMI and received the artery-opening treatment may be eligible to join, as long as they can safely have an MRI scan. Participants can expect to have blood tests, heart ultrasounds, and MRI scans done when they first come to the hospital, before they leave, and again six months later. Doctors will also check how well their heart is working and look for any changes that might affect their health. This study aims to help doctors better understand recovery after a heart attack and improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • STEMI
- Exclusion Criteria:
- • Contraindication to CMR imaging
About University Of Pisa
The University of Pisa is a prestigious academic institution renowned for its commitment to advancing scientific research and education. With a rich history dating back to the 12th century, the university is dedicated to fostering innovation and excellence in various fields, including medicine and health sciences. As a clinical trial sponsor, the University of Pisa leverages its robust research infrastructure and interdisciplinary expertise to conduct rigorous clinical studies aimed at improving patient outcomes and contributing to the body of medical knowledge. Its collaborative approach involves partnerships with healthcare institutions and industry stakeholders, ensuring that research is aligned with the highest ethical standards and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pisa, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported